Figure S1 | RBC freezing with novel small molecule IRIs. The effect of NOGlc (4), β-PMP-Glc (6) and sucrose on postthaw RBC integrities. RBC samples in indicated cryo-solutions containing no (0%) or 20% glycerol in a dextrose/saline buffer were slow-cooled 1 °C/min to defined sub-zero temperatures and then rapidly cooled (cooling rate approximately 115 o C/min) by immersion into liquid nitrogen and stored at -196 °C. All samples were quickly thawed at 37 °C and post-thaw hemolysis was quantified post-thaw using Drabkin's assay to determine % RBC integrity (100 -% hemolysis). Error bars represent SEM. Asterisks indicate statistical significance relative to the glycerol control as determined by two-tailed unpaired student's T-test: *, p <0.05; **, p < 0.01; ***, p < 0.001.
Figure S2 | Toxicity of β-PMP-Glc (6), β-pFPh-Glc (12) and β-pBrPh-Glc (13) cryo-solutions on RBCs. RBC integrities after room temperature incubation for indicated time period with cryo-solutions without freezing. Hemolysis was quantified post-thaw using Drabkin's assay to determine % RBC integrity (100 -% hemolysis). Error bars represent SEM. 
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Supplementary Methods
General Experimental:
All anhydrous reactions were performed in flame-dried glassware under a positive pressure of dry argon. Air or moisture-sensitive reagents and anhydrous solvents were transferred with oven-dried syringes or cannulae. All flash chromatography was performed with E. Merck silica gel 60 (230-400 mesh). All solution phase reactions were monitored using analytical thin layer chromatography (TLC) with 0.2 mm pre-coated silica gel aluminum plates 60 F254 (E. Merck). Components were visualized by illumination with a short-wavelength (254 nm) ultraviolet light and/or staining (ceric ammonium molybdate, potassium permanganate, or phosphomolybdate stain solution). All solvents used for anhydrous reactions were distilled. Tetrahydrofuran (THF) and diethyl ether (Et 2 O) were distilled from sodium/benzophenone under nitrogen. Dichloromethane (DCM) was distilled from calcium hydride. N,N-dimethylformamide (DMF) was stored over activated 4Å molecular sieves under argon. 1 H (400 or 500 MHz) and 13 C NMR (100 or 125 MHz) spectra were recorded at ambient temperature on a Bruker Avance 400, Bruker Avance 500, or Varian Inova 500 spectrometer. Deuterated chloroform (CDCl 3 ) or water (D 2 O) were used as NMR solvents, unless otherwise stated. Chemical shifts are reported in ppm using the solvent residual peak as an internal standard. Splitting patterns are designated as follows: s, singlet; d, doublet; t, triplet; q, quartet; quint, quintet; m, multiplet and br, broad. Low resolution mass spectrometry (LRMS) was performed on a Micromass Quatro-LC Electrospray spectrometer with a pump rate of 20 μL/min using electrospray ionization (ESI).
Compounds below are in order of appearance in the manuscript. Intermediates that were not numbered in the manuscript received numbers beginning with 12. NMR spectra for novel compounds and final compounds assessed for IRI activity are provided. 
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Synthesis
p-Methoxyphenyl-β-D-galactopyranoside (5)
Compound 5a (5.3 g, 11.6 mmol) was dissolved in a solution of sodium methoxide in methanol (25 mL) and stirred for one hour at room temperature. The solution was then neutralized with Amberlite® IR-120 (H + ) ionexchange resin and filtered. The filtrate was concentrated and the product was lyophilized to yield 5 as a white powder (3.3 g, 98%). Characterization data is consistent with that previously reported 1 
Ethyl 1-thio-α-D-Mannopyranoside (18)
Compound 17 (2.7 g, 6.9 mmol) was dissolved in a solution of sodium methoxide in methanol (10 mL) and stirred for one hour at room temperature. The solution was neutralized with Amberlite® IR-120 (H + ) ion-exchange resin, filtered and concentrated to yield 18 as a solid (1.5 g, 95%). Characterization data is consistent with that previously 
Ethyl 4,6-O-Benzylidene-2,3-O-Benzyl-1-thio-α-D-Mannopyranoside (19)
To a solution of 18 (375 mg, 1.67 mmol) in DMF (3 mL) was added benzaldehyde dimethyl acetal (251 μL, 1.67 mmol) and catalytic p-toluenesulfonic acid. The solution was stirred under reduced pressure at 60 °C for 3 hours then cooled to room temperature and triethylamine (50 μL) was added. The mixture was then evaporated and crystallized from CH 2 Cl 2 /pet. ether to afford 360 mg (69%) of the crude product that was used without further purification. The crude product (166 mg, 0.53 mmol) was dissolved in DMF (5 mL) and to this solution was added NaH (85 mg, 2.12 mmol) and the mixture was stirred for 10 min. Benzyl bromide (189 μL, 1.59 mmol) was added, followed by a catalytic amount of tetrabutylammonium iodide and the reaction mixture was stirred S7 
p-Methoxyphenyl-4,6-O-Benzylidene-2,3-O-Benzyl-β-D-Mannopyranoside (21)
Glycosidation conditions to form the β-linked mannopyranoside were as described by Crich et al 7, 8 . 
p-Methylphenyl-2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside (9a)
Compound 9a was prepared in a similar manner as 6a from 1,2,3,4,6-penta-O-acetyl-β-D-glucopyranose (500 mg, 
p-Methylphenyl-β-D-glucopyranoside (9)
Compound 9a (124 mg, 0.28 mmol) was dissolved in a solution of sodium methoxide in methanol (5 mL) and stirred for one hour at room temperature. The solution was then neutralized with Amberlite® IR-120 (H + ) ionexchange resin, filtered and concentrated. The product was purified by recrystallization in hot ethyl acetate to afford 9 as a white powder (68 mg, 89%). Characterization data is consistent with that previously reported in the 
Phenyl-2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside (10a)
Compound 10a was prepared in a similar manner as 6a from 1,2,3,4,6-penta-O-acetyl-β-D-glucopyranose (500 mg, 
Phenyl-β-D-glucopyranoside (10)
Compound 10a (400 mg, 0.94 mmol) was dissolved in a solution of sodium methoxide in methanol (5 mL) and stirred for one hour at room temperature. The solution was then neutralized with Amberlite® IR-120 (H + ) ionexchange resin, filtered and concentrated. The filtrate was concentrated and the product was lyophilized to yield 10 as a white powder (229 mg, 95% 
p-Nitrophenyl-2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside (11a)
Compound 11a was prepared in a similar manner as 6a from 1,2,3,4,6-Penta-O-acetyl-β-D-glucopyranose (420 mg, 
m-Methoxyphenyl-β-D-glucopyranoside (14)
Compound 14a (162 mg, 0.33 mmol) was dissolved in a solution of sodium methoxide in methanol (5 mL) and stirred for one hour at room temperature. The solution was then neutralized with Amberlite® IR-120 (H + ) ionexchange resin, filtered and concentrated. The filtrate was concentrated and the product was lyophilized to yield 14 as a white powder (90 mg, 95%). 
